Clarity Pharmaceuticals: Clarity receives U.S. FDA Fast Track Designation for Cu-64 SAR-bisPSMA in biochemical recurrence of prostate cancer
Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to ...
Hosted on MSN19h
Supreme Court agrees to hear appeal of Quebec's secularism law
The Supreme Court of Canada's decision to hear a challenge of Quebec's secularism law sets up a final legal battle between ...